Professor R A Peters (1889-1982): British Anti-Lewisite (BAL) and treatment of post-arsphenamine jaundice

A. BAL (British Anti-Lewisite), 1941-1953
A.1/1-6 Reports 1941-1950 A.2 Specifications
A.3/1-5 MRC BAL Conferences/BAL and Allied Substances Committee
A.4 Letters re publications on BAL
A.5 Correspondence on Italian newspaper articles on BAL

B. Arsphenamine jaundice and methionine, 1943-1945

>Letters to and from Peters and between his associates.

Admiralty, Medical Department of the Navy A.3/1
Air Ministry Medical Service A.3/5
Allen, J A.4
American Embassy , OSRD Office, Johnson, John R A.2
Amor, AJ, Ministry of Supply A.1/5
Anderson, TE A.3/5, B.1
Animal Diseases Research Association, Stewart, I A.3/5
Australian Scientific Research Liaison Office, Bull, LB A.3/5
Barnes, JM A.3/3
Bensted, HJ B.2
Berk, Messrs FW and Co Ltd, Law, JA, Works Manager A.3/5
Biochemical Journal, King, EJ, Editor A.4
Blair, DM , South Africa, Office of the Secretary of Health/Dept of Health, Southern Rhodesia A.3/2, A.3/3
Boots Pure Drug Co A.4
- Broom, WA A.3/2
- Coppock, JBM A.3/5
- Dale, HE A.3/2
- Drummond, JL A.3/3
- Garforth, B A.1/5, A.2, A.3/1, A.3/5
- Harvey, EA A.3/2
- Hobday, GI A.3/3
- Marshall, J A.4
- Parkinson, Marshall, Production Planning Office A.2
- Smith, KL A.1/5
- Thomson, WAR A.3/3
- Williams, JRF A.3/3
Boyland, E A.2
British Council, Rome, Tahourdin, P A.3/3
British Drug Houses
- Brown, H Trevor A.3/2, A.3/3
- Carr, FH A.3/5
British Medical Bulletin, Popjak, H, Subeditor A.4
British Pharmacopoiea Commission, Denston, TC, Deputy Secretary A.3/3, A.3/5
Broom, WA, Boots Pure Drug Co A.3/2
Brown, H Trevor, British Drug Houses A.3/2, A.3/3
Brull, L A.4
Buffa, P A.5
Bull, LB, Australian Scientific Research Liaison Office A.3/5
Burn, JH A.1/1, A.3/3, A.5
Bywaters, EGL A.3/5
Calder, R A.1/1
Cambridge University Press
- Syndics of A.4
- University Printer, Johnson, D for A.4
Cameron, GR , Porton Experimental Station A.3/4
Carleton, Alice A.3/5
Carr, FH, British Drug Houses A.3/5
Cartledge, L A.3/5
Chandler, Joy S, Rheumatism Research Unit of the South West and Oxford Regions A.3/3
Charterhouse Rheumatism Clinic, Coke, Harry A.3/5
Chemical Research Defence, Ministry of Supply, Williams, Ltd A.2
Coke, Harry, Charterhouse Rheumatism Clinic A.3/5
Commission Internationale Permanente pour la Medicine du Travail, Davies, HJ, A.4
Cooke, AM B.2
Copeman, WSC, Savage, OA for A.3/5
Coppock, JBM, Boots Pure Drug Co A.3/5
Cunningham, IJ, Superintendent, Wallaceville Animal Research Station, New Zealand A.3/5
Currie, AN, Factory Dept, Ministry of Labour and National Service A.3/2
Cuthbertson, DP, Medical Research Council A.2, A.3/5, B.2
D'Adintorio, G A.5
Dale, HE, Boots Pure Drug Co A.3/2
De, HN A.3/3
Danielli, JF A.3/5
Davies, HJ, Commission Internationale Permanente pour la Medicine du Travail A.4
Denston, TC, Deputy Secretary, British Pharmacopoiea Commission A.3/3, A.3/5
Din, GM A.3/5
Drummond, JL, Boots Pure Drug Co A.3/3
Eason, EF, Chemical Defence Research Establishment, Ministry of Supply A.1/4
Edoardo, C A.5
Ellis, A, Medical Research Council A.1/5
Fairley, A A.1/1, A.1/2, A.3/5
Felton, CS, Chief, Medical Section, Monsanto Chemical Co A.3/5
Forgan, R, May and Baker Ltd A.3/3
Foster, WR, Ministry of Supply A.3/1
Fullerton, A A.3/5
Gaddum, JH A.1/5, A.2, A.3/1, A.3/2, A.3/5
Galway, County MOH A.3/5
Gamble, JA, Editor in Chief, Journal of Clinical Investigation A.4
Garforth, B, Boots Pure Drug Co A.1/5, A.2, A.3/1, A.3/5
Gilbert, HH, Medical Superintendent, Quebec A.3/5
Glasgow Public Health Dept, Moore, WR A.3/5
Glaxo Laboratories, Tomick, EG A.3/2
Graham, JDP A.3/5
Granger, AF A.1/5
Green, FHK, Medical Research Council A.3/3
Greenwood, M B.1, B.2
Guzman Barron, ES A.4
Haarer, Herbert Assistant Secretary , St John d'el Rey Mining Co Ltd A.3/1
Haddon, CE, Ministry of Supply B.1
Hammond, Dr A.3/5
Harmsworth, WP , Johnson Matthey and Co Ltd A.3/5
Harrison, K, Porton A.1/2, A.2, A.3/4
Harrison, LW , Ministry of Health A.3/4
Hartog, JM, National Research Development Corporation A.3/3
Hartley, P, National Institute for Medical Research A.1/5
Harvey, EA , Boots Pure Drug Co A.3/2
Harvier, P A.3/5
Hawking, F, National Institute for Medical Research A.3/5
Heath, JC, Strangeways Research Laboratory A.3/3
Herrald, FJC, Medical Research Council A.1/5, A.2, A.3/1, A.3/2, A.3/3, A.3/5
Himsworth, HP, Medical Research Council A.3/3
Hobday, GI, Boots Pure Drug Co A.3/3
Holmes, GA, Agricultural Liaison Officer, New Zealand A.3/5
Holmes, LHA, Ministry of Supply A.2
Howarth, AT A.4
Imperial Chemical Industries Ltd, Thelwall Jones, A A.3/2, A.3/5
Ingrassia, G A.5
International Paint and Compositions Co Ltd, Robinson, R, Chief Chemist A.3/5
Irwin, JO, London School of Hygiene and Tropical Medicine Statistical Research Unit A.3/2
Jealott's Hill Research Station, Thruston, MN A.3/5
Johnson, D for University Printer, Cambridge University Press A.4
Johnson, John R, OSRD Office, American Embassy A.2
Johnson Matthey and Co Ltd, Harmsworth, WP A.3/5
Journal of Clinical Investigation, Gamble, JA, Editor in Chief A.4
Kellaway, CH, Wellcome Research Institution A.3/1
Kalkar, HM A.3/5
King, AJ A.3/5, B.1, B.2
King, EJ, Editor, Biochemical Journal A.4
Kingan, R, British Chemical Warfare Representative, Washington
A.3/5, A.4
Kirner, W R, USA National Defence Research Committee A.1/1, A.2
Klaber, R A.2
Kucy, A A.3/2
Lamotte-Barrillon, S A.3/5
Law, JA, Works Manager, Berk, Messrs FW and Co Ltd A.3/5
Lawrence, AJL, Ministry of Supply A.2
Levvy, GA A.4, B.2
Lewart, RM A.3/3
London School of Hygiene and Tropical Medicine Statistical Research Unit, Irwin, JO, A.3/2
Longscope, WT A.4
Lorenzo, L A.3/3
Lourie, EM A.3/3
McCance, RA A.3/5
McFarlan, AM B.1
Tooke, E pp B.2
MacFarlane, WV A.3/5
McKenna, R, War Office B.2
McKenna, RAB A.3/5
MacLeod, JG A.3/5
McQuillin, FJ, Ministry of Supply A.2
Mandelbrote, B A.3/5
Maestra Santi, L A.5
Marotta, D A.5
Marshall, J, Boots Pure Drug Co A.4
Martin, WJ B.2
May and Baker Ltd, Forgan, R, A.3/3
Mazzei, ES A.3/2
Medical Director-General, Medical Department of the Navy,
Admiralty A.3/1
Medical Research Council
- Cuthbertson, DP A.2, A.3/5, B.2
- Ellis, A A.1/5
- Green, FHK A.3/3
- Herrald, EJC A.1/5, A.2, A.3/1, A.3/2, A.3/3, A.3/5
- Himsworth, HP A.3/3
- Mellanby, E A.3/4
- Thompson, JLS, Secretary to Dr Herrald A.3/1, A.3/5
- Whittaker, JD A.4
Meerapfel, O A.3/5
Mellanby, E, Medical Research Council A.3/4 `
Middlehurst, WH, for Sutcliffe, Speakman and Co Ltd, Engineers A.2
Miles, AA, National Institute for Medical Research A.1/5,A.3/1
Ministry of Health, Harrison, LW A.3/4
Ministry of Labour and National Service, Currie, AN, Factory Dept A.3/2
Ministry of Supply [see also Porton Experimental Station]
- Amor, AJ A.1/5
- Chief Controller Chemical Defence A.3/1
- Foster, WR A.3/1
- Haddon, CE B.1
- Holmes, LHA A.2
- Inspectorate of Medical Supplies, Rothery Mr A.2
- Lawrence, AJL A.2
- McQuillin, J A.2
- Owen, GA A.4
- Phillips, JWC, Superintendent, Research Establishment A.3/1
- Randall, WMS A.1/1, A.1/2, A.2
- Short, EI A.1/2, A.1/3
- Uffelmann, FR A.1/2, A.1/4, A.1/5, A.2, A.3/1, A.3/4, A.3/5, A.4
- Wheeler, CR A.1/1, A.2
- Williams, LTD A.1/1, A.2
- Woodward, FN A.1/5
Mond Nickel Co Ltd, Morgan, JG A.3/5
Monsanto Chemical Co, Felton, CS, Chief, Medical Section A.3/5
Moore, WR, Glasgow Public Health Dept A.3/5
Morgan, JG, Mond Nickel Co Ltd A.3/5
Morris, RM, South Africa, Office of the Secretary of Health/ Southern Rhodesia, Dept of Health A.3/3
Müller, AW A.3/5
Müller, J A.5
National Institute for Medical Research
- Hartley, P A.1/5
- Hawking, F A.3/5
- Miles, AA A.1/5, A.3/1
National Research Development Corporation
- Hartog, JM A.3/3
- Zvegintzov, M A.3/3
Nemmarino, E A.5
New Zealand
- Holmes, GA, Agricultural Liaison Officer A.3/5
- Wallaceville Animal Research Station Cunningham, IJ, Superintendent A.3/5
Ormerod, CJ A.3/5
OSRD Office, American Embassy, Johnson, John R A.2
Owen, GA, Ministry of Supply A.4
Owen, LN A.3/1, A.3/3, A.3/5
Paluch, E, State Institute of Hygiene, Poland A.3/5
Parkes, GD A.5
Parkinson, Marshall, Production Planning Office, Boots Pure Drug Co A.2
Perales, N A.3/3
Peters ADK, Royal Ordnance Factory A.3/3
Phillips, JWC, Superintendent, Ministry of Supply Research Establishment A.3/1
Pimazzoni, D A.5
Poland, Paluch, E, State Institute of Hygiene A.3/5
Poole, LT B.1, B.2
Popjack, H, Subeditor, British Medical Bulletin, A.4
Porton Experimental Station
- Cameron, GR A.3/4
- Chief Superintendant A.2
- Eason, EF A.1/4
- Gaddum, JR A.2
- Harrison, K A.1/2, A.2, A.3/4
Pratt, JD B.1
Prosser Thomas, EW A.4
Quebec, Gilbert, HH, Medical Superintendent A.3/5
Radcliffe, W A.3/5
Randall, WMS, Ministry of Supply A.1/1, A.1/2, A.2
Reeve, JL A.3/5
Rheumatism Research Unit of the South West and Oxford Regions, Chandler, Joy S A.3/3
Rimington, C A.3/5
Ritchie-Russell, W A.5
Rittey, DAW A.3/2, A.3/3
Robinson, R, Chief Chemist, International Paint and Compositions Co Ltd A.3/5
Rothery, Mr, Inspectorate of Medical Supplies, Ministry of Supply A.2
Royal Ordnance Factory, Peters ADK A.3/3
Royal Society, Salisbury, E A.4
St John d'el Rey Mining Co Ltd,
- Herbert Haarer Assistant Secretary A.3/1
- Managing Director A.3/1
Salisbury, E, Royal Society A.4
Savage, OA for Copeman, WSC A.3/5
Short, EI, Ministry of Supply A.1/2, A.1/3
Smith, KL, Boots Pure Drug Co A.1/5
Society of Cosmetic Chemists of Great Britain, Wells, FV A.5
South Africa, Office of the Secretary of Health
- Blair, DM A.3/2
- Morris, RM A.3/3
Southern Rhodesia, Dept of Health
- Blair DM A.3/2, A.3/3
- Morris, RM A.3/3
Spray, GH A.4
Stewart, I, Animal Diseases Research Association A.3/5
Stocken, LA A.1/5, A.2, A.3/1, A.3/2
Storey, I A.4
Strangeways Research Laboratory, Heath, JC A.3/3
Stuart, AM A.4
Sutcliffe, Speakman and Co Ltd, Engineers, Middlehurst, WH for A.2
Tahourdin, PA, British Council, Rome A.3/3, A.5
Taylor, JA A.3/5
Thelwall Jones, A, Imperial Chemical Industries Ltd A.3/2, A.3/5
Thompson, JLS, Secretary to Dr Herrald, Medical Research Council A.3/1, A.3/5
Thompson, RHS A.1/5, A.2, A.3/1, A.3/2, A.3/3, A.3/5, A.5
Thomson, WAR, Boots Pure Drug Co A.3/3
Tomick, EG, Glaxo Laboratories A.3/2
Tooke, E pp McFarlan, AM B.2
Thruston, MN, Jealott's Hill Research Station A.3/5
Uffelmann, FR, Ministry of Supply A.1/2, A.1/4, A.1/5, A.2, A.3/1, A.3/4, A.3/5, A.4
USA National Defence Research Committee, Kirner, W R, A.1/1,A.2
van der Horst, L A.3/5
Wallaceville Animal Research Station, New Zealand, Cunningham, IJ, Superintendent A.3/5
War Office, McKenna, R B.2
Weatherhead, M A.5
Wellcome Research Institution, Kellaway, CH A.3/1
Wells, FV, Society of Cosmetic Chemists of Great Britain A.5
Wheeler, CR, Ministry of Supply A.1/1, A.2
Whittaker, JD, Medical Research Council A.4
Williams, DI A.3/5, B.1, B.2
Williams, JRF, Boots Pure Drug Co A.3/3
Wilson, G A.3/4
Williams, LTD, Chemical Research Defence Dept, Ministry of Supply A.1/1, A.2
Woodward, FN, Ministry of Supply A.1/5
Wormall, A A.4
Young, FG A.3/1
Zvegintzov, M, National Research Development Corporation A.3/3